Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Leflunomide and anthralin may effectively treat severe alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

MK-5108 is safe and shows potential against tumors, especially alone.

Canakinumab's effect on COVID-19 outcomes is unclear.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.